RESUMO
Leukocyte adhesion deficiency type I (LAD-I) is a rare, inherited immunodeficiency with defect in the recruitment of leukocyte to the site of inflammation. Patients with severe LAD-I have absent or markedly reduced expression of CD18 and CD11. Here we report clinical profile of 7 cases of LAD-I diagnosed at our center over a period of 3 years. Recurrent skin and mucous membrane infections were the major presenting manifestations. All children had a history of delayed cord separation.
Assuntos
Antígenos CD11/análise , Antígenos CD18/análise , Síndrome da Aderência Leucocítica Deficitária , Leucócitos/imunologia , Contagem de Células Sanguíneas , Pré-Escolar , Feminino , Seguimentos , Humanos , Lactente , Recém-Nascido , Síndrome da Aderência Leucocítica Deficitária/sangue , Síndrome da Aderência Leucocítica Deficitária/diagnóstico , Síndrome da Aderência Leucocítica Deficitária/imunologia , MasculinoRESUMO
A retrospective review of ten patients (8 girls, 2 boys) admitted over a 9-month period with haemophagocytic lymphohistiocytosis (HLH) is presented. Presenting features included fever and hepatosplenomegaly (10), bleeding manifestations (7), lymphadenopathy (4), skin rash (4), shock (4), jaundice (3), CNS disorder (3), renal failure (2) and arthritis (2). Three infants had familial HLH (FHL) while the other seven patients had acquired (secondary) HLH. Two patients with FHL had very low perforin levels (0 and 0.05%). There was secondary HLH owing to systemic onset juvenile idiopathic arthritis in two patients, and one each had anaplastic large cell lymphoma, measles with pneumonia, disseminated tuberculosis, dengue hemorrhagic fever and lymphoproliferative disorder. Cytopenia affecting two or three lineages in peripheral blood was present in all while haemophagocytosis in bone marrow was documented in nine patients .Other important laboratory parameters were raised ferritin (9), raised LDH (9), hypertriglyceridaemia (7) and hypofibrinogenaemia (5). The patients were treated according to the HLH2004 protocol. Diagnosis of HLH should be considered early in patients presenting with unremitting fever, hepatosplenomegaly and cytopenias as without appropriate treatment HLH is usually fatal.
Assuntos
Linfo-Histiocitose Hemofagocítica/diagnóstico , Linfo-Histiocitose Hemofagocítica/patologia , Adolescente , Antineoplásicos/administração & dosagem , Criança , Pré-Escolar , Ciclosporina/administração & dosagem , Dexametasona/administração & dosagem , Etoposídeo/administração & dosagem , Feminino , Humanos , Índia , Lactente , Linfo-Histiocitose Hemofagocítica/complicações , Linfo-Histiocitose Hemofagocítica/tratamento farmacológico , Masculino , Metotrexato/administração & dosagem , Estudos RetrospectivosAssuntos
Lúpus Eritematoso Sistêmico/complicações , Mielofibrose Primária/etiologia , Biópsia por Agulha , Medula Óssea/patologia , Criança , Feminino , Seguimentos , Glucocorticoides/administração & dosagem , Humanos , Lúpus Eritematoso Sistêmico/tratamento farmacológico , Lúpus Eritematoso Sistêmico/patologia , Prednisolona/administração & dosagem , Mielofibrose Primária/tratamento farmacológico , Mielofibrose Primária/patologiaRESUMO
Severe aplastic anemia (SAA) in children has been previously treated with high dose methyl prednisolone (HDMP) with favorable results. We reviewed our experience with intravenous HDMP. Seven children with a diagnosis of SAA confirmed on bone marrow biopsy were treated with 300 mg/kg total dose of intravenous HDMP over a 4 week period. Patients were closely monitored for response and side effects. HDMP was well tolerated except for hyperglycemia in one case. Six of the seven patients showed no response to HDMP. This observation is in stark contrast with previous trials on use of HDMP in SAA. It is concluded that HDMP should be reserved only for patients with milder bone marrow hypoplasia.
Assuntos
Anemia Aplástica/tratamento farmacológico , Anti-Inflamatórios/uso terapêutico , Metilprednisolona/uso terapêutico , Anemia Aplástica/diagnóstico , Anemia Aplástica/fisiopatologia , Anti-Inflamatórios/administração & dosagem , Criança , Pré-Escolar , Relação Dose-Resposta a Droga , Feminino , Humanos , Infusões Intravenosas , Masculino , Metilprednisolona/administração & dosagem , Resultado do TratamentoAssuntos
Antineoplásicos/uso terapêutico , Interferon-alfa/uso terapêutico , Leucemia Mielogênica Crônica BCR-ABL Positiva/tratamento farmacológico , Antineoplásicos/administração & dosagem , Evolução Fatal , Humanos , Lactente , Interferon alfa-2 , Interferon-alfa/administração & dosagem , Leucemia Mielogênica Crônica BCR-ABL Positiva/diagnóstico , Leucemia Mielogênica Crônica BCR-ABL Positiva/fisiopatologia , Masculino , Proteínas RecombinantesRESUMO
An epidemic of an infection associated with circulating hemophagocytes (HP) and activated monocytes (AM) was seen in Bombay. Although certain features overlapped with the well-defined entity of virus-associated hemophagocytic syndrome and familial hemophagocytic lymphohistiocytosis, it was distinct enough to place it in a separate category. Affected children were predominantly two days to two years of age. They had fever, altered sensorium, neurological symptoms, dyspnea, and/or diarrhea, and significant bleeding. Laboratory tests showed neutrophilia, AM and HP's in every blood smear, coagulopathy, normal cerebrospinal fluid, normal liver transaminases, hypertriglyceridemia, and hypoalbuminemia. Surgical cases were remarkable in that they had small bowel malformations. These cases were subdivided into four distinct groups based on age of presentation, neonates, infants, children and a surgical group. The clinical differences in each group are described.
Assuntos
Surtos de Doenças , Histiocitose de Células não Langerhans/etiologia , Diagnóstico Diferencial , Transtornos Hemorrágicos/etiologia , Histiocitose de Células não Langerhans/complicações , Histiocitose de Células não Langerhans/diagnóstico , Histiocitose de Células não Langerhans/epidemiologia , Humanos , Índia/epidemiologia , Lactente , Recém-Nascido , PrognósticoRESUMO
The clinical data and hematological features of 29 children, under the age of 12 years, with primary myelodysplasia are presented. The diagnosis was made using the FAB (French-American-British) Cooperative Group criteria. There were 24 males and 5 females aged 4 months to 12 years (median 2.5 years) with marked male preponderance. Childhood myelodysplasia constituted 16% of all hematological malignancies and 36.7% of acute myeloid leukemias. The median duration of symptoms prior to diagnosis was 3 months. There were 15 cases of refractory anemia, one of refractory anemia with excess blasts, 3 of refractory anemia with excess blasts in transformation and 10 cases of chronic myelomonocytic leukemia. Five patients evolved to acute myeloid and 4 to acute lymphatic leukemia. The median duration of preleukemic phase in these patients was 7 months (range 4-29 months). The overall mean survival was short (5-9 months) in all the subgroups. Besides supportive therapy in most patients, two patients were treated with etoposide, one with alfa interferon 2b and one with high dose methylprednisolone. Our results show that myelodysplasia is not infrequent in children. The disease has an aggressive clinical course and may evolve into acute leukemia.
Assuntos
Países em Desenvolvimento , Síndromes Mielodisplásicas/etiologia , Criança , Pré-Escolar , Diagnóstico Diferencial , Feminino , Seguimentos , Humanos , Índia , Lactente , Leucemia/diagnóstico , Leucemia/mortalidade , Masculino , Síndromes Mielodisplásicas/mortalidade , Pré-Leucemia/diagnóstico , Pré-Leucemia/mortalidade , Taxa de SobrevidaAssuntos
Histiocitose de Células de Langerhans/complicações , Histiocitose de Células não Langerhans/complicações , Desamino Arginina Vasopressina/uso terapêutico , Histiocitose de Células de Langerhans/tratamento farmacológico , Histiocitose de Células de Langerhans/fisiopatologia , Histiocitose de Células não Langerhans/tratamento farmacológico , Histiocitose de Células não Langerhans/fisiopatologia , Humanos , Lactente , Pulmão/fisiopatologia , MasculinoAssuntos
Imunodeficiência de Variável Comum/complicações , Síndromes de Imunodeficiência/complicações , Injeções Intramusculares , Neutropenia/complicações , Neutropenia/tratamento farmacológico , Periodicidade , gama-Globulinas/administração & dosagem , gama-Globulinas/uso terapêutico , Humanos , Lactente , Masculino , Neutrófilos , Resultado do TratamentoAssuntos
Enterocolite Pseudomembranosa/diagnóstico , Neutropenia/diagnóstico , Leucemia-Linfoma Linfoblástico de Células Precursoras/diagnóstico , Pré-Escolar , Colo/patologia , Enterocolite Pseudomembranosa/patologia , Evolução Fatal , Humanos , Índia , Intestino Delgado/patologia , Masculino , Neutropenia/patologia , Leucemia-Linfoma Linfoblástico de Células Precursoras/patologiaAssuntos
Tumor do Seio Endodérmico/secundário , Germinoma/secundário , Metástase Neoplásica , Neoplasias da Medula Espinal/patologia , Bleomicina/administração & dosagem , Bleomicina/uso terapêutico , Criança , Cisplatino/administração & dosagem , Cisplatino/uso terapêutico , Terapia Combinada , Dexametasona/administração & dosagem , Dexametasona/uso terapêutico , Tratamento Farmacológico , Tumor do Seio Endodérmico/tratamento farmacológico , Tumor do Seio Endodérmico/radioterapia , Feminino , Germinoma/tratamento farmacológico , Germinoma/radioterapia , Humanos , Imageamento por Ressonância Magnética , Medula Espinal/patologia , Medula Espinal/fisiopatologia , Medula Espinal/efeitos da radiação , Neoplasias da Medula Espinal/radioterapia , Vimblastina/administração & dosagem , Vimblastina/uso terapêuticoRESUMO
Twelve cases of endodermal sinus tumor were reviewed. There were 10 females and 2 males with a median age at presentation of 3 years. The primary site was sacrococcygeal in 4 patients, vaginal in 3, retroperitoneal in 2, and testicular, ovarian and left chest wall in one each. The diagnosis rested on histopathological examination and elevation of serum alfa feto protein levels (median 46,200 ng/ml). Two patients had Stage I disease, 9 had Stage III and one had Stage IV disease. Patients were managed by surgery and chemotherapy (BVP regime). All patients on BVP (even those lost at later stages), had achieved clinical remission with the first cycle of treatment.
Assuntos
Tumor do Seio Endodérmico , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Neoplasias Ovarianas , Neoplasias Retroperitoneais , Região Sacrococcígea , Neoplasias Testiculares , Neoplasias Torácicas , Neoplasias VaginaisRESUMO
Clinical and hematological data of 9 cases with factor XIII deficiency is highlighted. The age at first bleed ranged from 3 days of life to 1 year. Seven of these 9 cases had bleeding from the umbilicus, 3 had recurrent subcutaneous and muscle hematomas, while 4 cases had CNS bleeds of which 3 expired. Routine coagulogram was normal, while clot solubility in 5 molar urea solution was abnormal in all cases. Factor XIII assay was not done in any. Patients were treated with plasma transfusion during episodes of bleeding. No patient received plasma transfusion as prophylactic therapy. The cumulative Indian data so far documented, inclusive of this series, shows a very high incidence of CNS bleeds (33%) in patients with this inherited coagulation disorder.
Assuntos
Deficiência do Fator XIII/congênito , Hemorragia Cerebral/etiologia , Deficiência do Fator XIII/complicações , Feminino , Humanos , Lactente , Recém-Nascido , MasculinoRESUMO
From May 1985 to December 1989, while doing blood counts on hospitalized children in Bombay, over 300 blood smears showed an impressive number of activated monocytes (AMs) and hemophagocytes (HPs). Many AMs resembled macrophages. The AM-HPs were visible in blood for 1-10 days, accompanied by a neutrophilia and a marked thrombocytopenia. Clinical features associated with these smears were fever, unresponsiveness to antibiotics, symptoms referable to the CNS and respiratory and/or gastrointestinal tracts, and bleeding. Ninety percent of affected children were under 2 years of age. The illness resolved completely or was fatal in 30%, with bleeding or respiratory failure, within 2 weeks. Children older than 2 years had underlying illness and high fever, and 40% died. Surgical candidates had obstructive gastrointestinal pathologic findings, from the stomach to the ileum. Babies under 1 month of age died, with clinical signs of deterioration and bleeding. Bone marrows were unremarkable. Few or no AM-HPs were seen. The fibrin split product tests were positive. Liver function test results were normal. Autopsies on six cases revealed edema and bleeding or thrombosis in the lungs, brain, and gastrointestinal tract. Only one neonate had a mild histiocytic infiltration in the lungs and liver. Features in common with and differences from virus-associated hemophagocytic syndromes are discussed.